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Abstract The biological role of diadenosine oligophosphates 
(DAOP) remains obscure in spite of numerous attempts to solve 
this enigma. It is known that Ap:iA contrary to Ap4A 
accumulates in human cultured cells treated with interferons 
(IFNs) alpha or gamma. Since IFNs are considered as 
antiproliferative regulators, we assumed that different cell status 
may be associated with varying intracellular levels of DAOP. 
Promyelocytic human cell line HL60 induced by phorbol ester 
(TPA) to differentiate to macrophage-like cells in culture 
exhibits a profound loss of proliferative potential. Here we have 
shown a 4-5-fold increase in Ap3A concentration in HL60 cells 
induced by TPA, similar to the effect of IFN, while the Ap4A 
concentration remained unchanged. On the contrary, in cells 
undergoing apoptosis induced by VP16, a topoisomerase II 
inhibitor, the Ap:!A concentration considerably decreased, while 
the Ap4A concentration increased. These findings combined with 
earlier results suggest an involvement of the Ap3 A/Ap4A ratio in 
signal transduction pathways controlling the cell status. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Aminoacyl-tRNA synthetases (ARS, E.C. 6.1.1) in the pres-
ence of ATP, ADP and substrate amino acids are synthesising 
diadenosine oligophosphates (DAOP) (reviewed in [1-3]). 
Most of the ARS generate AP4A from aminoacyl adenylate 
enzyme complex and ATP, while some other are capable of 
producing Ap3A from adenylate and ADP. Mammalian tryp-
tophanyl-tRNA synthetase (WRS, E.C. 6.1.1.2) contrary to 
the majority of other ARS cannot produce AP4A, but synthe-
sises readily the Ap3A [4]. This peculiar property of WRS is 
accompanied by another unusual feature, that is, inducibility 
by IFNs [5,6]. Human WRS gene possesses regulatory ele-
ments GAS and ISRE [7] typical for IFN-inducible genes 
(reviewed in [8,9]). Furthermore, these two independent ob-
servations are related since it was shown that WRS induction 
by IFNs was associated with Ap3A accumulation in IFN-
treated cells while the AP4A concentration was not affected 
[10]. Several hypotheses have already been suggested to ex-
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plain the role of WRS in IFN signalling pathway [11], includ-
ing those where the major role of WRS response to IFNs was 
ascribed to the ability of WRS to produce Ap3A, not AP4A 
rather then to its main function, tryptophanyl-tRNA forma-
tion. It was suggested [11] that Ap3A/Ap4A ratio may serve 
for IFN-induced signal transduction. Since IFNs possess 
along with other activities a strong antiproliferative capacity, 
one of the consequences of the above mentioned hypothesis is 
that cell status may be somehow associated with intracellular 
Ap3A/Ap4A ratio. 
To test this experimentally, we have explored the advan-
tages of a human promyelocytic cell line HL60 capable to 
undergo either differentiation to macrophage-like cells in-
duced by phorbol esters like TPA [12], or apoptosis provoked 
by an inhibitor of DNA topoisomerase activity, VP16 [13]. 
Here, we have compared the Ap3A and Ap4A content in 
HL60 cells at four different cultivation conditions: uninduced 
and induced by TPA, VP16, or IFNce. The entirely opposite 
effect observed in differentiating and apoptotic cells with re-
gard to the Ap3A/Ap4A ratio is fully consistent with the idea 
of involvement of Ap3A/Ap4A ratio in cell signalling path-
ways. 
2. Materials and methods 
2.1. Cell labelling and DAOP detection 
The HL60 human myeloid leukaemia cell line was grown in RPMI 
medium supplemented with 10% foetal calf serum. Before addition of 
IFNa (1000 IU/ml), or TPA (150 ng/ml) or VP16 (20 μg/ml) cells were 
grown 24 h with [32P]orthophosphate (50 μθ/piιΐ, 5000 Ci/mmol). For 
extraction of DAOP, 10% ice-cold perchloric acid was mixed with 
2.0-2.5 X 107 of cells. After 10 min on ice with gentle shaking the 
mixture was centrifuged 10 min at lOOOXg and the supernatant was 
neutralised with 5 M K2CO3. The pellet was discarded and the neu-
tralised extract was treated with E. coli alkaline phosphatase (1.25 μg/ 
ml in 25 mM Tris-HCl, pH 8.0 and 10 mM MgCl2) 3 h at 37°C. After 
4-fold dilution with water the extract was applied on a DEAE-cellu-
lose column (0.8x10 cm) and nucleotides were eluted with a linear 
0.2-0.8 mM of NH4HCO3, pH 8.2 (12 ml/h). Thin-layer chromatog-
raphy of DAOP was performed on Silufol (Kavalier, Czechoslovakia). 
For autoradiography, the dried plates were kept in contact with X-ray 
film (Kodak X-Omat AR) for 48 h. In order to estimate the amount 
of the labelled nucleotides, the corresponding areas were removed 
from plates and counted in the toluene scintillation liquid. 
2.2. Induction of apoptosis and examination of DNA 
The HL60 cells were incubated in the presence or absence of 20 μg/ 
ml of VP16. Cells were lysed by addition to the culture medium of 5 X 
lysis buffer (2 M NaCl, 50 mM Tris-HCl, 10 mM Na EDTA, pH 8.1, 
1% SDS, 0.25 mg/ml of proteinase K), and DNA was extracted by the 
salting-out method. Electrophoresis was carried out on 1% agarose gel 
containing 0.5 μg/ml ethidium bromide. 
2.3. Fluorescent microscopic identification of apoptotic cells 
Suspensions of control and VP16-treated cells were centrifuged for 
5 min at 1000 Xg, the pellet was resuspended in serum-free medium, 
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Fig. 1. DAOP content in IFN- and TPA-treated HL60 cells. A: Control (1); IFN: 15 h (2); 22 h (3); TPA: 48 h (4); Ap4A content (5). 
B: TLC of labeled DAOP on Silufol plates. IFN: 22 h (1); control (2). 
centrifuged once more and resuspended in PBS. Then, cell smears 
were prepared, dried, fixed with 70% ethanol, stained with 1 μg/ml 
of Hoechst 33258 (Sigma) in PBS, embedded in glycerol and examined 
under Leitz fluorescent microscope (Ob.X60) for the presence of 
apoptotic cells with fragmented pycnotic nuclei. 
3. Results 
3.1. DAOP synthesis in IFNa- and TPA-treated cultured 
human cells 
The Ap3A content in HL60 cells incubated with IFNoc for 
15 h and 22 h increased 1.8- and 3.2-fold, respectively, over 
the control (non-treated) level of 4.8 pmol/106 of cells (Fig. 1). 
The level of AP4A was considerably lower (0.46 pmol/106 of 
cells) and was not affected by IFN treatment of cells. These 
results are compatible with the data obtained earlier with non-
induced human cell cultures [2]. 
TPA-treated HL60 cells exhibit intense adherence to plastic 
with prominent pseudopodia formation in parallel with a rap-
id profound loss of proliferative capacity. We measured the 
ApnA concentration in untreated and TPA-treated cells. It 
appeared that after 48 h incubation with TPA the Ap3A con-
tent significantly increased and reached the level of 24 pmol/ 
106 of cells. In control cells the level of Ap3A was 5.2 pmol/ 
106 of cells. The Ap4A content was insensitive to TPA treat-
ment. 
3.2. DAOP in HL60 cells undergoing to apoptosis 
The treatment of HL60 cells with VP16 resulted in gradual 
accumulation of apoptotic cells characterised by fragmented 
nuclei with condensed chromatin as revealed by staining with 
a DNA-specific fluorochrom Hoechst 33258 (Fig. 2A). In con-
trol cultures apoptotic cells represented less than 0.5% of total 
cell population. Their proportion increased to 9% after 6 h 
and further to 35% at 24 h of VP16 treatment. DNA extracted 
from VP-treated HL60 cells showed a characteristic fragment 
size distribution after pulsed-field gel electrophoresis (Fig. 
2B). The DNA fragments about 50 kbp in length were accu-
mulated in response to VP16 treatment for 3 h. The second 
component of DNA fragmentation, the characteristic DNA 
Fig. 2. VP16-induced apoptosis in HL60 cells. A: An apoptotic cell characterised by nuclear fragmentation and chromatin condensation and 
two normal cells. HL60 cells were treated with VP16 for 6 h. Fixed cells smear was stained with Hoechst 33258 and photographed. B: Agarose 
gel electrophoresis of total cellular DNA from HL60 cells showing the pattern typical for apoptosis. Lane 1, molecular weight markers (6X174 
DNA cleaved with HaelW). DNA extracted from control HL60 cells at O time and after 10 h of cultivation (lane 7). DNA extracted from 
HL60 cells incubated with VP16 for 5, 10, 15 and 20 h (lanes 3-6, respectively). 
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Fig. 3. Ap3A and Ap4A content in VP16-treated HL60 cells. 
ladder of 200 bp (Fig. 2B) occurred when the cells became 
smaller after 10 h incubation with VP16. The full apoptosis 
was detected at 20 h of incubation with VP16. 
The Ap3A and Ap4A concentrations in HL60 cells incu-
bated with VP16 at various time intervals were measured. It 
appeared that the AP3A concentration tremendously de-
creased during the first 10 h of treatment with VP16; during 
the second 10 h of incubation with VP16 the level of Ap3A 
didn't change significantly. At the same conditions the Ap4A 
concentration reached 2.7 pmol/106 of cells. Ap4A was de-
tected in control cells at the level of 0.7 pmol/106 of cells. 
4. Discussion 
We have observed for the first time that apoptosis is asso-
ciated with a dramatic inversion of the Ap3A/Ap4A ratio. In 
normally proliferating HL60 cells this molar ratio is roughly 
7 while in the highly apoptotic cell culture it drops to about 
0.5 (Fig. 3). This inversion is due to elevation of Ap4A con-
centration in apoptotic cells and drop of Ap3A level. The 
entirely opposite effect was observed when HL60 cells under-
go differentiation (Fig. 1): the Ap4A concentration remained 
constant whereas the Ap3A level was manyfold elevated. The 
analysis of data available in literature implies that (i) active 
cell proliferation is usually associated with the elevation of 
Ap4A level while the opposite states such as quiescence and 
differentiation have no significant effect on the Ap4A concen-
tration. It is also interesting to note that in most available 
cases the intracellular concentration of Ap3A moved in a di-
rection opposite to that of Ap4A. Consequently, it appears 
that Ap3A/Ap4A ratio rather than their concentrations taken 
separately is the most sensitive indicator of cell status. In this 
connection, it is necessary to stress that, as we have demon-
strated, the Ap3A/Ap4A ratio shows polarly distinct behav-
iour in apoptotic versus differentiating HL60 cells. These data 
indicate a profound difference between the apoptosis and dif-
ferentiation signalling in myelomonocytic cells, though the 
process of differentiation is usually accompanied with some 
degree of apoptosis [14]. Indeed, numerous observations have 
already shown that apoptosis and differentiation may be con-
sidered as alternative outcomes for proliferating leukaemic 
cells. Thus, the forced expression of the bcl-2 gene not only 
prevents the apoptosis of leukaemic cells but also induces the 
transition from cell cycle to Go state typical for differentiation 
[15]. Some inducers of differentiation like a derivative of vita-
min D protect HL60 cells from apoptosis [16]. At the same 
time, some early effects of differentiation and apoptosis in-
ducers, such as transient hyperexpression of c-fos and c-jun 
genes, are strikingly similar [17]. This is why the new data 
pertaining to the differences in cell signalling during apoptosis 
and differentiation are of considerable value. These data are 
helpful for understanding the mechanisms of these two alter-
native processes in leukaemic cells and are also of potential 
usefulness for the development of new chemotherapeutic ap-
proaches. 
The potential signalling mechanisms relating the intracellu-
lar Ap3A/Ap4A ratio and cell status remain obscure. Several 
proteins were identified as possessing an Ap4A binding ability 
[18-20]. We have detected in human cultured cells three pro-
teins specific for the Ap3A binding (A. Vartanian, unpub-
lished observations). We assume that one of the most plausi-
ble ways to influence the cell behaviour via Ap3A/Ap4A ratio 
may rely on competition between binding of various DAOP to 
different proteins which may serve as signal transducers in 
bound or unbound state. Obviously, this speculation deserves 
further experimental verification. 
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